下载本文档
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemENVP-BSK805 dihydrochlorideCat. No.: HY-14722ACAS No.: 1942919-79-0Synonyms: BSK805 dihydrochloride分式: CHClFNO分量: 563.47作靶点: JAK作通路: Epigenetics; JAK/STAT Signaling; Stem Cell/Wnt储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C
2、6 months-20C 1 month溶解性数据体外实验 DMSO : 50 mg/mL (88.74 mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 1.7747 mL 8.8736 mL 17.7472 mL5 mM 0.3549 mL 1.7747 mL 3.5494 mL10 mM 0.1775 mL 0.8874 mL 1.7747 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。体内实验请根据您的实验动物和给药式选择适当的溶解案,配制前请先配制
3、澄清的储备液,再依次添加助溶剂(为保证实验结果的可靠性,体内实验的作液,建议您现现配,当天使;澄清的储备液可以根据储存条件,适当保存;以下溶剂前的百分 指该溶剂在您配制终溶液中的体积占):1. 请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (4.44 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-CD in saline)Solubility: 2.5 mg/mL (4.44 mM); Clear solution3. 请依序添
4、加每种溶剂: 10% DMSO 90% corn oil1/3 Master of Small Molecules 您边的抑制剂师www.MedChemESolubility: 2.5 mg/mL (4.44 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 NVP-BSK805 dihydrochloride种 ATP 竞争性的 JAK2 抑制剂,对 JAK2 JH1 (JAK 同源1),JAK1JH1,JAK3 JH1,和 TYK2 JH1 的 IC50 值分别为 0.48 nM,31.63 nM,18.68 nM 和 10.76 nM。IC50 & Ta
5、rget JAK2 JH1 FL JAK2 V617F FL JAK2 wt TYK2 JH10.48 nM (IC50) 0.56 nM (IC50) 0.58 nM (IC50) 10.76 nM (IC50)JAK3 JH1 JAK1 JH118.68 nM (IC50) 31.63 nM (IC50)体外研究 NVP-BSK805 dihydrochloride is a JAK2 inhibitor, with IC50s of 0.48 nM, 31.63 nM, 18.68 nM, and 10.76 nMfor JAK2 JH1 (JAK homology 1), JAK1 J
6、H1, JAK3 JH1, and TYK2 JH1, respectively. NVP-BSK805 inhibitsthe full-length wild-type JAK2 (FL JAK2 wt) and FL JAK2 V617F activity, with IC50s of 0.58 0.03 and 0.56 0.04 nM. NVP-BSK805 is ATP-competitive, with aclculated Ki of 0.43 0.02 nM. NVP-BSK805 suppressesthe growth of JAK2V617F-bearing acute
7、 myeloid leukemia cell lines with GI50 of V617F-mutant cell lines 1.NVP-BSK805 (5 M) improves P-gp inhibitory activity. NVP-BSK805 increases sensitization of drug-resistantKBV20C cancer cells to VIC treatment at 10 M, and such an effect is more effective than a 5 M dose 2.体内研究 NVP-BSK805 (150 mg/kg,
8、 p.o.) blocks STAT5 phosphorylation, splenomegaly, and leukemic cell spreadingin a Ba/F3 JAK2V617F cell-driven mouse model. NVP-BSK805 (50, 75, and 100 mg/kg, p.o.) alsosuppresses rhEpo-mediated polycythemia and splenomegaly in BALB/c mice 1.PROTOCOLCell Assay 1 The antiproliferative activity of JAK
9、2 inhibitors is determined by incubating cells for 72 hours (96 hours forMB-02 and MUTZ-8 cells) with an 8-point concentration range of NVP-BSK805 and cell proliferation relativeto NVP-BSK805 is measured using the colorimetric WST-1 cell viability readout. Of each triplicate treatment,the mean is ca
10、lculated and these data are plotted in XLfit 4 to determine the half-maximal growth inhibition(GI50) values 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Mice 1Administration 1 Concomitantly with NVP-BSK805 treatment, female BALB/c mice recei
11、ve daily s.c. injections (in 100 Lsaline buffer) of 10 units of rhEpo for 4 consecutive days. Controls are injected corresponding volumes ofsaline buffer. Mice are sacrificed 24 hours after the final dose and total blood, spleen, and bone marrow aretaken for further analysis. Animals are 8 to 10 wee
12、ks of age at treatment start (20-25 g body weight) and arekept under optimal hygienic conditions with free access to food and water 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.2/3 Master of Small Molecules 您边的抑制剂师www.MedChemE户使本产品发表的科研献 Patent. US
13、20180263995A1.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Baffert F, et al. Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805. Mol Cancer Ther. 2010Jul;9(7):1945-55.2. Cheon JH, et al. The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancercells to vincristine. Biochem Biophys Res Commun. 2017 Sep 2;490(4):1176-1182.
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 部编版小学语文三年级上册第四单元知识点归纳与单元检测试卷(共五套)
- 管道工程识图及施工工艺讲义
- 4.9数组常用算法-专题辅导课件
- 交通事故后申请书7篇
- 2022-2023学年北京清华育才实验学校高一数学文知识点试题含解析
- 珍珠泉教学反思8篇
- 降低毕业论文查重率的方法3
- 河北省张家口市石窑子中学高一数学文月考试题含解析
- 中班语言领域春节教案5篇
- 信息与编码理论 第2版 课件 5.3 线性分组码
- 【国企】钢结构施工工艺指导手册
- 层面解剖与层面外科课件
- 芜湖老船厂改造城市设计概念方案设计2016
- 基于主题意义探究的初中英语读写教学
- 《观察与比较》教学设计公开课
- 天津市新版就业、劳动合同登记名册
- LNG加气站生产安全事故综合应急预案
- 医院手术分级管理制度
- 神经系统通过下丘脑控制内分泌系统课件-高二上学期生物浙科版选择性必修1
- 劳务派遣管理服务方案人员培训方案外包服务方案汇总
- 质量管理制度执行情况检查考核记录表
评论
0/150
提交评论